DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,487 filers reported holding DANAHER CORPORATION in Q1 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,514,553 | +5.0% | 6,105 | +1.5% | 0.18% | +6.1% |
Q2 2023 | $1,442,880 | -9.4% | 6,012 | -4.9% | 0.16% | -10.3% |
Q1 2023 | $1,592,641 | -5.9% | 6,319 | -0.9% | 0.18% | -6.1% |
Q4 2022 | $1,692,849 | +3.7% | 6,378 | +0.9% | 0.20% | -5.8% |
Q3 2022 | $1,633,000 | +2.7% | 6,322 | +0.8% | 0.21% | +7.8% |
Q2 2022 | $1,590,000 | -14.7% | 6,272 | -1.3% | 0.19% | -4.9% |
Q1 2022 | $1,865,000 | -7.4% | 6,357 | +3.8% | 0.20% | +0.5% |
Q4 2021 | $2,014,000 | +14.7% | 6,122 | +6.2% | 0.20% | -42.1% |
Q3 2021 | $1,756,000 | +13.4% | 5,767 | 0.0% | 0.35% | +14.1% |
Q2 2021 | $1,548,000 | +19.3% | 5,767 | 0.0% | 0.31% | +12.1% |
Q1 2021 | $1,298,000 | +1.3% | 5,767 | 0.0% | 0.27% | -4.9% |
Q4 2020 | $1,281,000 | +3.1% | 5,767 | 0.0% | 0.29% | -7.7% |
Q3 2020 | $1,242,000 | +64.3% | 5,767 | +34.8% | 0.31% | +52.5% |
Q2 2020 | $756,000 | +27.7% | 4,277 | 0.0% | 0.20% | +11.5% |
Q1 2020 | $592,000 | -9.6% | 4,277 | +0.2% | 0.18% | +8.3% |
Q4 2019 | $655,000 | +4.1% | 4,269 | -2.0% | 0.17% | -5.1% |
Q3 2019 | $629,000 | -1.3% | 4,355 | -2.2% | 0.18% | -3.3% |
Q2 2019 | $637,000 | +8.3% | 4,455 | 0.0% | 0.18% | +1.7% |
Q1 2019 | $588,000 | +28.1% | 4,455 | 0.0% | 0.18% | +15.3% |
Q4 2018 | $459,000 | -5.2% | 4,455 | 0.0% | 0.16% | +2.6% |
Q3 2018 | $484,000 | +10.0% | 4,455 | 0.0% | 0.15% | +0.7% |
Q2 2018 | $440,000 | +0.9% | 4,455 | 0.0% | 0.15% | -12.1% |
Q1 2018 | $436,000 | +5.3% | 4,455 | 0.0% | 0.17% | +7.5% |
Q4 2017 | $414,000 | -4.6% | 4,455 | -11.9% | 0.16% | -8.0% |
Q3 2017 | $434,000 | -5.0% | 5,055 | -6.6% | 0.18% | -9.8% |
Q2 2017 | $457,000 | +7.5% | 5,412 | +9.0% | 0.19% | +0.5% |
Q1 2017 | $425,000 | +9.8% | 4,967 | 0.0% | 0.19% | 0.0% |
Q4 2016 | $387,000 | +5.7% | 4,967 | +6.4% | 0.19% | -4.0% |
Q3 2016 | $366,000 | -22.3% | 4,667 | 0.0% | 0.20% | -27.2% |
Q2 2016 | $471,000 | – | 4,667 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
MIROVA | 128,368 | $16,947,000 | 9.18% |
Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |